Status of Cardiovascular PET Radiation Exposure and Strategies for Reduction: An Information Statement from the Cardiovascular PET Task Force
Overview
Affiliations
Cardiovascular positron emission tomography (PET) imaging provides high-quality visual and quantitative myocardial perfusion and function images. In addition, cardiovascular PET can assess myocardial viability, myocardial inflammatory disorders such as cardiac sarcoid, and infections of implanted devices including pacemakers, ventricular assist devices, and prosthetic heart valves. As with all nuclear cardiology procedures, the benefits need to be considered in relation to the risks of exposure to radiation. When performed properly, these assessments can be obtained while simultaneously minimizing radiation exposure. The purpose of this information statement is to present current concepts to minimize patient and staff radiation exposure while ensuring high image quality.
Wen F, Liu Y, Wang H Cells. 2022; 11(21).
PMID: 36359759 PMC: 9654984. DOI: 10.3390/cells11213363.
Totzeck M, Aide N, Bauersachs J, Bucerius J, Georgoulias P, Herrmann K Eur J Nucl Med Mol Imaging. 2022; 50(3):792-812.
PMID: 36334105 PMC: 9852191. DOI: 10.1007/s00259-022-05991-7.
Kersten J, Eberhardt N, Prasad V, Kessler M, Markovic S, Morike J Front Cardiovasc Med. 2021; 8:713625.
PMID: 34527713 PMC: 8435679. DOI: 10.3389/fcvm.2021.713625.
Bays H, Khera A, Blaha M, Budoff M, Toth P Am J Prev Cardiol. 2021; 6:100176.
PMID: 34327499 PMC: 8315431. DOI: 10.1016/j.ajpc.2021.100176.
Juneau D, Wu K, Kaps N, Yao J, Renaud J, Beanlands R J Nucl Cardiol. 2021; 28(3):835-850.
PMID: 33389638 DOI: 10.1007/s12350-020-02464-y.